in Newswire January 10, 2017

Sanofi, U.S. Facing Antitrust Class Action Over Insulin Product

by Corrado Rizzi

Last Updated on January 10, 2017

Cesar Castillo, Inc. v. Sanofi, U.S. et al

Filed: January 10, 2017 § 1:17-cv-10042

A proposed class action has been filed against Sanofi, U.S. and Sanofi GmbH claiming the companies violated federal antitrust laws.






Last Updated on January 10, 2017 — 3:01 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.